Bridget Finnerty

611 total citations
7 papers, 379 citations indexed

About

Bridget Finnerty is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Bridget Finnerty has authored 7 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in Bridget Finnerty's work include Angiogenesis and VEGF in Cancer (3 papers), Cell Adhesion Molecules Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). Bridget Finnerty is often cited by papers focused on Angiogenesis and VEGF in Cancer (3 papers), Cell Adhesion Molecules Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). Bridget Finnerty collaborates with scholars based in United States. Bridget Finnerty's co-authors include Montserrat Arumí-Uría, N. Scott McNutt, Daniel J. Hicklin, Rajiv Bassi, Yan Wu, Jon A. Reed, Anthony P. Albino, James R. Tonra, Jacqueline Doody and Paul Kussie and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and American Journal Of Pathology.

In The Last Decade

Bridget Finnerty

7 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bridget Finnerty United States	6	212	169	78	45	41	7	379
Montserrat Arumí-Uría Spain	9	252 1.2×	235 1.4×	101 1.3×	135 3.0×	29 0.7×	13	498
Christin A. Hamilton United States	7	320 1.5×	100 0.6×	53 0.7×	39 0.9×	136 3.3×	9	506
Bonnie Gould Rothberg United States	5	272 1.3×	165 1.0×	37 0.5×	54 1.2×	61 1.5×	6	392
Shauna Hegarty Ireland	11	324 1.5×	171 1.0×	238 3.1×	75 1.7×	65 1.6×	12	656
Katja Muehlethaler Switzerland	6	422 2.0×	231 1.4×	88 1.1×	115 2.6×	87 2.1×	6	554
Kenji Nakamaru Japan	10	296 1.4×	217 1.3×	75 1.0×	42 0.9×	18 0.4×	23	512
Linda Potter United Kingdom	7	350 1.7×	220 1.3×	81 1.0×	55 1.2×	53 1.3×	9	450
Ewelina Dratkiewicz Poland	12	235 1.1×	177 1.0×	75 1.0×	56 1.2×	107 2.6×	13	403
Aleksandra Simiczyjew Poland	16	295 1.4×	213 1.3×	101 1.3×	115 2.6×	124 3.0×	29	555
R. Hein Germany	10	290 1.4×	189 1.1×	85 1.1×	69 1.5×	116 2.8×	11	486

Countries citing papers authored by Bridget Finnerty

Since Specialization

Citations

This map shows the geographic impact of Bridget Finnerty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bridget Finnerty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bridget Finnerty more than expected).

Fields of papers citing papers by Bridget Finnerty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bridget Finnerty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bridget Finnerty. The network helps show where Bridget Finnerty may publish in the future.

Co-authorship network of co-authors of Bridget Finnerty

This figure shows the co-authorship network connecting the top 25 collaborators of Bridget Finnerty. A scholar is included among the top collaborators of Bridget Finnerty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bridget Finnerty. Bridget Finnerty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Tuma, M. Carolina, Asra Malikzay, Xiaohu Ouyang, et al.. (2010). Antitumor Activity of IMC-038525, a Novel Oral Tubulin. Translational Oncology. 3(5). 318–325. 28 indexed citations

2.

Wu, Yan, Zhaojing Zhong, James Huber, et al.. (2006). Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for Cancer. Clinical Cancer Research. 12(21). 6573–6584. 120 indexed citations

3.

Prewett, Marie, James R. Tonra, Rajiv Bassi, et al.. (2004). Antitumor activity of a novel, human anti-epidermal growth factor receptor (EGFR) monoclonal antibody (IMC-11F8) in human tumor xenograft models. Cancer Research. 64. 1235–1235. 13 indexed citations

4.

Wu, Yan, Zhaojing Zhong, Huiling Li, et al.. (2004). A fully human monoclonal antibody against VEGFR-1 inhibits growth of human breast cancers. Cancer Research. 64. 694–695. 1 indexed citations

5.

Arumí-Uría, Montserrat, N. Scott McNutt, & Bridget Finnerty. (2003). Grading of Atypia in Nevi: Correlation with Melanoma Risk. Modern Pathology. 16(8). 764–771. 86 indexed citations

6.

Liao, Fang, Jacqueline Doody, Jay Overholser, et al.. (2002). Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.. PubMed. 62(9). 2567–75. 86 indexed citations

7.

Reed, Jon A., Bridget Finnerty, & Anthony P. Albino. (1999). Divergent Cellular Differentiation Pathways during the Invasive Stage of Cutaneous Malignant Melanoma Progression. American Journal Of Pathology. 155(2). 549–555. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact